Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

The Research Authority serves as the administrative and financial framework for research activities, scientific experiments and technical analyses carried out by Technion faculty, and TRDF staff. The missions of the Research & Development Division are: - Location, collection, processing and distribution of information concerning local and international research funding - Assistance in locating appropriate funding sources for Technion researchers - R&D information management services and in-campus marketing - Guidance and administrative services for Technion researchers in submitting research proposals to granting agencies and business entities - Management of contractual engagements with granting agencies and business entities - Contractual and budgetary administration of research grants and other accounts

Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery SIGMACEPTOR™ platform. The Anavex portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. The company’s lead drug candidate for Alzheimer’s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose (SAD) clinical trial. The company has also started scale-up manufacturing for ANAVEX 1-41, its second lead compound, targeting depression and AD. With sufficient quantities of ANAVEX 1-41 in hand, the company will be in a position to advance the program and begin preclinical studies on large animals in the near term.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Harbin Institute of Technology (Shenzhen) (HITSZ; Chinese: 哈尔滨工业大学深圳校区), was established in 2002 as a satellite graduate school of the Harbin Institute of Technology. Currently, over 3,000 graduate students attend HITSZ situated in Shenzhen University Town, Nanshan District, Shenzhen. The campus has an area of 16.36 hectares of which 3.04 hectares are shared facilities with two other graduate schools of Tsinghua University and Peking University.

Shanghai Hequan Pharmaceutical Co., Ltd., established on 2003-01-23, Business scope includes pharmaceutical production(Production with license and approval);working on medicinal compounds,Research and development of chemical raw materials(except dangerous goods);R&D and production of industrial enzymes;Wholesale and import and export of medicinal compounds(Precursor chemicals excluded);R&D and production of pharmaceutical intermediates;Handling of Hazardous Chemicals(see license);Sell ​​self-produced products. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Hequan Drug Research and Development Co., Ltd., established on 2011-04-15, The business scope includes the research and development of pharmaceutical small molecule compounds(lab only),Research and development of drug synthesis process routes,medicine analysis,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shenzhen CNNC Headway Biotechnology Co., Ltd., established on 1996-08-09, Business scope includes general business items:Sales of Class I Medical Devices;Class I Medical Device Leasing;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Food Additive Sales;Domestic trade agent;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;IoT application service;rental service(Licensed rental services not included).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of Drug Testing Instruments;Manufacture of nuclear and nuclear radiation measuring instruments;Manufacturing of experimental analysis instruments;software sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Class B unsealed radioactive material workplace;Production of Class I Medical Devices;Production of Class II Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing;Food additive production;Healthy food(prepackaged)Sales;property management;Import and export;Technology Import and Export;Import and export agency;Disinfection equipment sales;Internet Information Service for Medical Devices;Drug internet information service;pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments);Production of new chemical substances;Drug Clinical Trial Services;Production of sterile equipment;Production of formula food for special medical purpose;nuclear material production;Production of Civilian Nuclear Materials;radioisotope production(In addition to radiopharmaceuticals for positron emission computed tomography).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)